ArticleInternational journal of molecular sciences2025
Neuroprotection by Flaxseed Oil in a Model of Hippocampal Injury Induced by Trimethyltin Involves Purinergic System Modulation.
Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
A large body of evidence suggests that flaxseed oil (FSO), one of the richest sources of essential omega-3 fatty acids, has neuroprotective properties. Purinergic signaling plays a crucial role in pathophysiological processes in the nervous system. There is a lack of evidence regarding the effects of FSO on the purinergic system under both physiological and neurotoxic conditions. Here we report the effects of dietary FSO consumption in a rat model of trimethyltin (TMT) intoxication. Exposure to TMT selectively induces hippocampal neuronal damage and glial reactivation associated with oxidative stress and neuroinflammation, causing severe behavioral impairments. When administered orally (1 mL/kg) before and during TMT intoxication (single dose 8 mg/kg, i.p.) to female Wistar rats, FSO effectively prevented the behavioral disturbances induced by TMT. FSO selectively increased CAT-mRNA level in both healthy and TMT-intoxicated animals, while preventing TMT-induced upregulation of Nrf2, NF-κB, and GPx1 without affecting SOD2 or Gsr-mRNA levels. FSO prevented microgliosis, microglial NTPDase1-eN upregulation, and the increase in purinergic receptors involved in microglial reactivity. Pretreatment with FSO in TMT-intoxicated rats maintained the activity and expression of NTPDase1 at control level, while the activity and expression of eN and ADA were increased. FSO upregulated eN, A
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.